Filing Flows › Champions Oncology (CSBR) › Q2 FY26
Champions Oncology (CSBR) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Dec 15, 2025
Champions Oncology (CSBR) reported revenue of $15.0M for the second quarter fiscal 2026 (Q2 FY26), +11% from a year earlier and +7% from the quarter before. Operating margin was 1.2%, net earnings $268K (1.8% of revenue).
Champions Oncology, Q2 FY26: revenue $15.0M (+12% year over year), operating margin 1.2%, net earnings $268K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.0M | +7% | +11% |
| Operating profit | $185K | — | -75% |
| Net earnings | $268K | — | -63% |
| Operating cash flow | −$1.7M | -389% | — |
What changed
Revenue was $15.0M in Q2 FY26, up 11% year over year and up 7% from the previous quarter. Pharmacology services was the largest line at 97% of revenue. Pharmacology services added $2.0M year over year (up 16%), 130% of the total change. Other TOS revenue declined 63%.
Operating profit was $185K, a 1.2% margin (down 4.2 points year over year). Operating profit fell $547K even though revenue rose $1.5M versus a year earlier, so costs grew faster than sales. Total costs grew 16% against revenue growth of 11%. The fastest-growing cost line was General & admin (+57%). Net earnings were $268K, down 63% year over year ($237K including minority interests, which bore $31K of losses). The effective tax rate was 7.1%. Non-operating items added $70K, 27% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.7M. Non-cash charges added back $357K of depreciation and amortization and $249K of share-based compensation. Working capital and other items used $2.6M. Capital expenditures of $242K exceeded it, leaving free cash flow of −$2.0M.
Questions
What was Champions Oncology's revenue in the second quarter fiscal 2026?
Champions Oncology (CSBR) reported revenue of $15.0M for the second quarter fiscal 2026 (Q2 FY26), +11% from a year earlier and +7% from the quarter before.
Was Champions Oncology profitable in the second quarter fiscal 2026?
Operating profit was $185K (1.2% of revenue) and net earnings $268K.
Source: Champions Oncology 10-Q on SEC EDGAR.